ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

ARTL Artelo Biosciences Inc

1,25
-0,09 (-6,72%)
27 Avr 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Artelo Biosciences Inc ARTL NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
-0,09 -6,72% 1,25 01:53:17
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,36 1,3109 1,36 1,3399 1,34
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
23/4/202414:30GLOBEArtelo Biosciences Announces Publication of Peer-Reviewed..
22/4/202414:30GLOBEArtelo Biosciences CEO to Appear on Benzinga All Access on..
25/3/202413:00GLOBEArtelo Biosciences Reports Fiscal 2023 Year-End Financial..
12/3/202414:15GLOBEArtelo Biosciences Selected as a Finalist in Johnson &..
23/1/202414:30GLOBEArtelo Biosciences Announces Publication of New..
08/1/202414:30GLOBEArtelo Biosciences Announces Selection of Worldwide Clinical..
05/12/202314:30GLOBEArtelo Biosciences Presents New Preclinical Data on ART12.11..
30/11/202315:00GLOBEArtelo Biosciences to Present Important New Preclinical Data..
13/11/202314:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202314:00GLOBEArtelo Biosciences Reports Third Quarter 2023 Financial..
09/11/202315:00GLOBEArtelo Biosciences Announces Publication of New..
02/11/202313:30GLOBEArtelo Biosciences to Present Preclinical Data Showcasing..
04/10/202314:30GLOBEPrincipal Investigator of Artelo’s CAReS Trial to..
13/9/202314:30GLOBEArtelo Biosciences to Present at the 13th Congress of the..
07/9/202314:00GLOBEArtelo Biosciences Completes Positive Pre-IND Meeting with..
06/9/202315:00GLOBEArtelo Biosciences to Present at the 6th Cannabinoid-Derived..
05/9/202315:00GLOBEArtelo Biosciences to Present at the H.C. Wainwright 25th..
10/8/202314:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202314:00GLOBEArtelo Biosciences Reports Second Quarter 2023 Financial..
08/8/202322:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202322:34EDGAR2Form 8-K - Current report
19/7/202315:00GLOBEArtelo Biosciences to Present New Mechanism of Action Data..
17/7/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
10/7/202314:30GLOBEArtelo Biosciences CEO to Participate in the Benzinga All..
07/7/202314:23EDGAR2Form DEL AM - Delaying amendment
06/7/202322:31EDGAR2Form S-3 - Registration statement under Securities Act of..
03/7/202320:15EDGAR2Form 8-K - Current report
03/7/202320:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/6/202314:30GLOBEArtelo Biosciences Announces Sponsorship of The William A...
27/6/202314:30GLOBEArtelo Biosciences Announces Important New Data on ART26.12..
26/6/202314:30GLOBEArtelo Biosciences Reports Superior Preclinical..
07/6/202314:30GLOBEArtelo Biosciences Selected for Oral Presentation to Report..
11/5/202314:00GLOBEArtelo Biosciences Reports First Quarter 2023 Financial..

Dernières Valeurs Consultées

Delayed Upgrade Clock